Damages of the price-fixing case of ‘Zofran’ and ‘Ondaron’ has been recomputed to KRW 1.2 billion

Published: 2015-03-04 14:44:22

Updated: 2015-03-04 14:44:22

The National Health Insurance Service (NHIS) raised damages for the reverse payment lawsuit case between GSK and Dong-A ST from KRW 470 million to KRW 1.2 billion.

At first, based on the economic analysis data of the Free Trade Commission, the NHIS computed damages by multiplication of requisitioned quantity decrease of ‘Zofran’ by the price difference between ‘Zofran (KRW 8,700)’ and ‘Ondaron...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.